Main menu button

News

Analysis Lammhults: Solid export growth, somewhat weaker in Sweden
06 feb 2019
Analysis Lammhults: Solid export growth, somewhat weaker in Sweden
Equity Research
Analysis, NeuroVive: Raising capital for clinical trials
23 jan 2019
Analysis, NeuroVive: Raising capital for clinical trials
Equity Research
Eq Research Serneke: Nice property deals- focus on Construction profits
23 jan 2019
Eq Research Serneke: Nice property deals- focus on Construction profits
Equity Research
Analysis Gunnebo: Better without France
16 jan 2019
Analysis Gunnebo: Better without France
Equity Research
Analysis, Annexin: Reduced visibility
07 jan 2019
Analysis, Annexin: Reduced visibility
Equity Research
Analysis, Saniona: Obestity treatment punches its weight
19 dec 2018
Analysis, Saniona: Obestity treatment punches its weight
Equity Research
Analysis Consilium: Turn-around on its way
14 dec 2018
Analysis Consilium: Turn-around on its way
Equity Research
Analysis, Biovica: Targets FDA clearance in 2020
14 dec 2018
Analysis, Biovica: Targets FDA clearance in 2020
Equity Research
Analysis TEO: Can only get better from here...
14 dec 2018
Analysis TEO: Can only get better from here...
Equity Research
Analysis FrontOffice: Turnaround case and Fintech in focus
07 dec 2018
Analysis FrontOffice: Turnaround case and Fintech in focus
Equity Research
Analysis Bublar: The next big game studio from Sweden?
05 dec 2018
Analysis Bublar: The next big game studio from Sweden?
Equity Research
Analysis, Nuevolution: Early projects showing strength
04 dec 2018
Analysis, Nuevolution: Early projects showing strength
Equity Research
Analysis, Brighter: In waiting mode
29 nov 2018
Analysis, Brighter: In waiting mode
Equity Research
Analysis, Svenska Aerogel: According to plan
29 nov 2018
Analysis, Svenska Aerogel: According to plan
Equity Research
Analysis, NeuroVive: Orphan drug portfolio growing up
27 nov 2018
Analysis, NeuroVive: Orphan drug portfolio growing up
Equity Research
Analysis Mytaste Group: Strong 3rd but will Q4 be a new record?
26 nov 2018
Analysis Mytaste Group: Strong 3rd but will Q4 be a new record?
Equity Research
Analysis Fastator: Still significant discount on NAV
23 nov 2018
Analysis Fastator: Still significant discount on NAV
Equity Research
Analysis MaxFastigheter: Good earnings and new projects
22 nov 2018
Analysis MaxFastigheter: Good earnings and new projects
Equity Research
Analysis Amasten: Constructing new values
21 nov 2018
Analysis Amasten: Constructing new values
Equity Research
Analysis Precise Biometrics: Strong growth anticipated around 2020
19 nov 2018
Analysis Precise Biometrics: Strong growth anticipated around 2020
Equity Research